Award
National Cancer Institute 5U54CA221704-08
Pilot Research Project: Evaluating Breast Cancer Patient Populations for Therapeutic Targeting of Aberrant p53, MDM2, MDMX, and PARP signaling
Recipient
Hunter College
Award Amount
$68,985.00
Ceiling
$68,985.00
Awarded
September 10, 2025
Identifier
5U54CA221704-08
Award for a pilot research project to evaluate breast cancer patient populations for therapeutic targeting of aberrant signaling pathways, focusing on expanding PARP inhibitor therapeutics beyond BRCA1 mutations.
Description
This project aims to analyze breast cancer samples for biomarkers related to aggressive breast cancer, with a focus on expanding PARP inhibitor therapeutics beyond BRCA1 mutations. The project involves collaboration between Hunter College and Temple University Fox Chase Cancer Center, with a focus on training and mentorship in cancer research.